Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 384

1.

Cachexia in rheumatoid arthritis is associated with inflammatory activity, physical disability, and low bioavailable insulin-like growth factor.

Engvall IL, Elkan AC, Tengstrand B, Cederholm T, Brismar K, Hafstrom I.

Scand J Rheumatol. 2008 Sep-Oct;37(5):321-8. doi: 10.1080/03009740802055984.

PMID:
18666027
2.

Effects of high-intensity resistance training in patients with rheumatoid arthritis: a randomized controlled trial.

Lemmey AB, Marcora SM, Chester K, Wilson S, Casanova F, Maddison PJ.

Arthritis Rheum. 2009 Dec 15;61(12):1726-34. doi: 10.1002/art.24891.

3.

Blockade of tumour necrosis factor-alpha in rheumatoid arthritis: effects on components of rheumatoid cachexia.

Metsios GS, Stavropoulos-Kalinoglou A, Douglas KM, Koutedakis Y, Nevill AM, Panoulas VF, Kita M, Kitas GD.

Rheumatology (Oxford). 2007 Dec;46(12):1824-7.

PMID:
18032540
4.

Rheumatoid cachexia: depletion of lean body mass in rheumatoid arthritis. Possible association with tumor necrosis factor.

Roubenoff R, Roubenoff RA, Ward LM, Holland SM, Hellmann DB.

J Rheumatol. 1992 Oct;19(10):1505-10.

PMID:
1464859
5.

Relationship between growth hormone-IGF-I-IGFBP-3 axis and serum leptin levels with bone mass and body composition in patients with rheumatoid arthritis.

Toussirot E, Nguyen NU, Dumoulin G, Aubin F, Cédoz JP, Wendling D.

Rheumatology (Oxford). 2005 Jan;44(1):120-5. Epub 2004 Oct 5.

PMID:
15466894
6.

Are insulin-like growth factor and its binding proteins 1 and 3 clinically useful as markers of malnutrition, sarcopenia and inflammation in end-stage renal disease?

Axelsson J, Qureshi AR, Divino-Filho JC, Bárány P, Heimbürger O, Lindholm B, Stenvinkel P.

Eur J Clin Nutr. 2006 Jun;60(6):718-26. Epub 2006 Jan 4.

PMID:
16391585
7.

Insulin-like growth factor I correlates with lean body mass in cystic fibrosis patients.

Sermet-Gaudelus I, Souberbielle JC, Azhar I, Ruiz JC, Magnine P, Colomb V, Le Bihan C, Folio D, Lenoir G.

Arch Dis Child. 2003 Nov;88(11):956-61.

8.

Association between insulin-like growth factor-I: insulin-like growth factor-binding protein-1 ratio and metabolic and anthropometric factors in men and women.

Sandhu MS, Gibson JM, Heald AH, Dunger DB, Wareham NJ.

Cancer Epidemiol Biomarkers Prev. 2004 Jan;13(1):166-70.

9.

What predicts obesity in patients with rheumatoid arthritis? An investigation of the interactions between lifestyle and inflammation.

Stavropoulos-Kalinoglou A, Metsios GS, Smith JP, Panoulas VF, Douglas KM, Jamurtas AZ, Koutedakis Y, Kitas GD.

Int J Obes (Lond). 2010 Feb;34(2):295-301. doi: 10.1038/ijo.2009.220. Epub 2009 Oct 27.

PMID:
19859075
10.

Interactions between insulin, body fat, and insulin-like growth factor axis proteins.

Ahmed RL, Thomas W, Schmitz KH.

Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):593-7.

11.

Association between insulin-like growth factor status and physical activity levels in rheumatoid arthritis.

Lemmey A, Maddison P, Breslin A, Cassar P, Hasso N, McCann R, Whellams E, Holly J.

J Rheumatol. 2001 Jan;28(1):29-34.

PMID:
11196538
12.
13.

Serum Sex Hormones, IGF-1, and IGFBP3 Exert a Sexually Dimorphic Effect on Lean Body Mass in Aging.

Waters DL, Yau CL, Montoya GD, Baumgartner RN.

J Gerontol A Biol Sci Med Sci. 2003 Jul;58(7):648-52.

PMID:
12865482
14.

Relations between body composition, functional and hormonal parameters and quality of life in healthy postmenopausal women.

Lebrun CE, van der Schouw YT, de Jong FH, Pols HA, Grobbee DE, Lamberts SW.

Maturitas. 2006 Aug 20;55(1):82-92. Epub 2006 Feb 23.

PMID:
16497451
15.

Pulmonary cachexia, systemic inflammatory profile, and the interleukin 1beta -511 single nucleotide polymorphism.

Broekhuizen R, Grimble RF, Howell WM, Shale DJ, Creutzberg EC, Wouters EF, Schols AM.

Am J Clin Nutr. 2005 Nov;82(5):1059-64.

PMID:
16280439
16.

Multidimensional reference regions for IGF-I, IGFBP-2 and IGFBP-3 concentrations in serum of healthy adults.

Mattsson A, Svensson D, Schuett B, Osterziel KJ, Ranke MB.

Growth Horm IGF Res. 2008 Dec;18(6):506-16. doi: 10.1016/j.ghir.2008.04.005. Epub 2008 Jun 11.

PMID:
18550406
17.

Muscle insulin-like growth factor status, body composition, and functional capacity in hemodialysis patients.

Macdonald JH, Phanish MK, Marcora SM, Jibani M, Bloodworth LL, Holly JM, Lemmey AB.

J Ren Nutr. 2004 Oct;14(4):248-52.

PMID:
15483786
18.

IGF system and peripheral arterial disease: relationship with disease severity and inflammatory status of the affected limb.

Brevetti G, Colao A, Schiano V, Pivonello R, Laurenzano E, Di Somma C, Lombardi G, Chiariello M.

Clin Endocrinol (Oxf). 2008 Dec;69(6):894-900. doi: 10.1111/j.1365-2265.2008.03269.x. Epub 2008 Apr 10.

PMID:
18410545
19.

Insulin resistance is associated with increased serum concentration of IGF-binding protein-related protein 1 (IGFBP-rP1/MAC25).

López-Bermejo A, Khosravi J, Fernández-Real JM, Hwa V, Pratt KL, Casamitjana R, Garcia-Gil MM, Rosenfeld RG, Ricart W.

Diabetes. 2006 Aug;55(8):2333-9.

20.

Serum insulin-like growth factor-axis and matrix metalloproteinases in patients with rheumatic arthritis or rheumatic heart disease.

Lee SD, Chen LM, Kuo WW, Shu WT, Kuo WH, Huang EJ, Tsai CC, Li PC, Liu JY, Chen TH, Huang CY.

Clin Chim Acta. 2006 May;367(1-2):62-8. Epub 2006 Jan 9.

PMID:
16406300

Supplemental Content

Support Center